Exo

BrainStorm Announces Scientific Presentation of NurOwn® Exosome Preclinical ARDS Data at NYSCF 2021 VIRTUAL Meeting

Monday, October 18, 2021 - 12:30pm

The NurOwntechnology platform (autologous MSC-NTF cells) represents a promising investigational therapeutic approach to targeting disease pathways important in neurodegenerative disorders.

Key Points: 
  • The NurOwntechnology platform (autologous MSC-NTF cells) represents a promising investigational therapeutic approach to targeting disease pathways important in neurodegenerative disorders.
  • MSC-NTF cells are produced from autologous, bone marrow-derived mesenchymal stem cells (MSCs) that have been expanded and differentiated ex vivo.
  • About BrainStorm Cell Therapeutics Inc.
    BrainStorm Cell Therapeutics Inc. is a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases.
  • Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements.

OpenExO Inc Introduces ExO Solutions

Thursday, October 14, 2021 - 1:44pm

MIAMI, Oct. 14, 2021 /PRNewswire/ -- OpenExO Inc, a public benefit organization that is transforming the world for a better future, has launched an ExO Solutions division to work with organizations including nonprofits, governments and all businesses to drive exponential transformation.

Key Points: 
  • MIAMI, Oct. 14, 2021 /PRNewswire/ -- OpenExO Inc, a public benefit organization that is transforming the world for a better future, has launched an ExO Solutions division to work with organizations including nonprofits, governments and all businesses to drive exponential transformation.
  • Since publishing Exponential Organizations over 6 years ago the OpenExO global community has worked with multiple organizations implementing ExO with amazing results.
  • ExO Solutions has been put together to augment the work that our community is doing and drive more transformation.
  • We have solutions for a range of organizations and situations and highly recommend that C-Suite executives and Board members join.

Odyssey Marine Exploration Announces Significant Debt Reduction and Continued Focus on Mineral Exploration and Development

Tuesday, October 5, 2021 - 1:30pm

This is a watershed moment for Odyssey Marine Exploration as we close an important chapter in our historythe legacy shipwreck exploration business, stated Mark D. Gordon, Odysseys Chairman and Chief Executive Officer.

Key Points: 
  • This is a watershed moment for Odyssey Marine Exploration as we close an important chapter in our historythe legacy shipwreck exploration business, stated Mark D. Gordon, Odysseys Chairman and Chief Executive Officer.
  • This expertise provided the platform for us to become a world leader in subsea mineral exploration, validation and development.
  • This will be a continued focus as we evaluate strategic investments and industry partnerships intended to position Odyssey for financial success in our subsea mineral exploration business, Jones continued.
  • Odyssey Marine Exploration, Inc. (Nasdaq:OMEX) is a deep-ocean exploration pioneer engaged in the discovery, validation, and development of subsea minerals deposits in a socially and environmentally responsible manner.

Exo Therapeutics Raises $78 Million Series B Financing

Tuesday, October 5, 2021 - 11:00am

Exo Therapeutics, Inc. , a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets, today announced the completion of a $78 million Series B financing.

Key Points: 
  • Exo Therapeutics, Inc. , a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets, today announced the completion of a $78 million Series B financing.
  • Exo is well positioned to capitalize on the tremendous opportunity that exosites represent, said Michael Bruce, PhD, CEO of Exo Therapeutics.
  • I am thrilled to work with Exo on building a robust pipeline of exosite-targeting therapeutics, said Schroeder.
  • Exo Therapeutics is a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets.

Ultrasound Disruptor Exo Secures $220M in Series C Funding Round

Monday, August 2, 2021 - 12:00pm

This scalable technology will allow Exo to widely distribute a device that aims to decentralize ultrasound while making it accessible everywhere.

Key Points: 
  • This scalable technology will allow Exo to widely distribute a device that aims to decentralize ultrasound while making it accessible everywhere.
  • Exo is a pioneer in ultrasound silicon technology, which is the foundation of its handheld ultrasound device that can be used for the entire body.
  • The team at Exo is made up of executives with deep ultrasound experience, MEMS expertise and consumer device development.
  • The Series C funding follows a successful Series B funding round for the Redwood City-based company, bringing Exos total funding to more than $320 million.

Blackline Safety’s G7 EXO wins gold at international design awards

Wednesday, July 21, 2021 - 2:17pm

Blackline Safety Corp. (TSX: BLN), a global leader of hardware-enabled software as a service (SaaS) technology, today announced its G7 EXO area gas monitor won gold at INT Designs 2021 GRANDS PRIX DU DESIGN awards.

Key Points: 
  • Blackline Safety Corp. (TSX: BLN), a global leader of hardware-enabled software as a service (SaaS) technology, today announced its G7 EXO area gas monitor won gold at INT Designs 2021 GRANDS PRIX DU DESIGN awards.
  • View the full release here: https://www.businesswire.com/news/home/20210721005599/en/
    Blackline Safety's G7 EXO is the world's first direct-to-cloud area gas monitor with integrated 4G cellular connectivity.
  • It is a pleasure to collaborate with the Blackline team to create enclosures that embody their amazing technology, said Alain Poirier, Senior Designer, Advanta Design.
  • About Blackline Safety: Blackline Safety is a global connected safety leader that helps to ensure every worker gets their job done and returns home safe each day.

Xentris Wireless Names Chris Whetstone as Director of Product Line Management of Military & Government Services

Tuesday, July 13, 2021 - 9:00pm

ADDISON, Ill., July 13, 2021 /PRNewswire/ --Xentris Wireless has named Chris Whetstone as Director of Product Line Management of Military & Government Services.

Key Points: 
  • ADDISON, Ill., July 13, 2021 /PRNewswire/ --Xentris Wireless has named Chris Whetstone as Director of Product Line Management of Military & Government Services.
  • In this role, Whetstone will be responsible for developing the company's EXO Charge product line which delivers dismounted power solutions that enhance the lethality of today's Warfighter.
  • He will serve as a senior member of the Military & Government Services business team.
  • "In his previous role as Group Product Leader of Military & Government Services, Chris has exceeded every expectation and has demonstrated outstanding leadership.

Blackline Safety Announces Record Q2 Revenue of $11.7m, up 38% Year Over Year

Thursday, June 24, 2021 - 1:00pm

Service revenue during the second quarter was $7,103, an increase of 8% compared to $6,564 in the same quarter last year.

Key Points: 
  • Service revenue during the second quarter was $7,103, an increase of 8% compared to $6,564 in the same quarter last year.
  • Blacklines product revenue was $4,572, an increase of 140% compared to $1,908 in the prior year.
  • Blackline continued strong sales of its new G7 EXO area gas monitor contributing $1,205 in product sales during the quarter.
  • About Blackline Safety: Blackline Safety is a global connected safety leader that helps to ensure every worker gets their job done and returns home safely each day.

"KWAVE Star Emoji" contest for the first time in US

Friday, June 11, 2021 - 3:34pm

LOS ANGELES, June 11, 2021 /PRNewswire/ -- A KWAVE Emoji contest with the theme of "Hallyu Star" will be held for the first time in the United States.

Key Points: 
  • LOS ANGELES, June 11, 2021 /PRNewswire/ -- A KWAVE Emoji contest with the theme of "Hallyu Star" will be held for the first time in the United States.
  • Ahead of the launch of KWAVE GO, a social network app aimed at Hallyu (Korea wave) fans around the world, KWAVE GO, inc is holding an "Hallyu Star" emoticon contest across the United States.
  • Hallyu stars mean such as BTS, Blackpink, Exo, Twice, Lee Min Ho, Hyun Bin etc.
  • Applicants can submit their favorite Hallyu star as a digital image file of characters expressing 16 different emotions.

Dr. Arun Nagdev Joins MedTech Startup Exo as Senior Director of Clinical Education Leading Exo's Ultrasound Education Efforts

Wednesday, May 26, 2021 - 2:00pm

REDWOOD CITY, Calif., May 26, 2021 /PRNewswire-PRWeb/ -- Dr. Arun Nagdev will join Exo (pronounced "Echo"), a health information and devices company, as the senior director of clinical education, leading the Silicon Valley company's expansive clinical education efforts.

Key Points: 
  • REDWOOD CITY, Calif., May 26, 2021 /PRNewswire-PRWeb/ -- Dr. Arun Nagdev will join Exo (pronounced "Echo"), a health information and devices company, as the senior director of clinical education, leading the Silicon Valley company's expansive clinical education efforts.
  • Dr. Nagdev joins Exo on the cusp of the company's launch of its patented handheld ultrasound device and intuitive workflow solution.
  • In his previous academic position, Dr. Nagdev started the point-of-care ultrasound program and fellowship at Brown University.
  • "Arun has been a powerful force in point-of-care ultrasound education and a champion for point-of-care ultrasound adoption," said Exo CEO Sandeep Akkaraju.